Dongmei Xu

ORCID: 0000-0003-3196-9220 · 3 papers in corpus
other 2026
CEBPD may function as a molecular indicator of fibrotic severity and negative regulator of fibrosis in uterine leiomyoma through regulating EMT progression
Frontiers in pharmacology ·doi:10.3389/fphar.2026.1839523

OBJECTIVE: To investigate the expression pattern, diagnostic value, and molecular mechanism of CCAAT/enhancer-binding protein delta (CEBPD) in uterine leiomyoma (ULM)-associated fibrosis, and to identify novel diagnostic biomarkers and ther…

lab-animal 2023
Atorvastatin exerts dual effects of lesion regression and ovarian protection in the prevention and treatment of endometriosis
European journal of pharmacology ·doi:10.1016/j.ejphar.2023.176261

Endometriosis is a frequent, chronic, estrogen-dependent and inflammatory gynecological disease leading to pain and infertility. Clinical and metabolic studies reveal that patients with endometriosis are susceptible to hyperlipemia and lipi…

2018
Predictive value of endometriosis fertility index in natural pregnancy outcome of patients with endometriosis and endometrial polyps after hysteroscopy combined with laparoscopic surgery
·doi:10.3760/cma.j.issn.2096-2916.2018.11.003

Objective To investigate the relationship of endometrial polyps (EPs) and endometriosis (EMS), and evaluate the predictive value of EMS fertility index (EFI) for women’s fertility with EMS combined with EPs. Methods A total of 248 in…